{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:20:26Z","timestamp":1793337626702,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["CS\/F\/21\/190049"],"award-info":[{"award-number":["CS\/F\/21\/190049"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ahj.2023.09.008","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T04:55:07Z","timestamp":1695876907000},"page":"149-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Rationale and study protocol for the BRITISH randomized trial (Using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy and severe systolic heart failure)"],"prefix":"10.1016","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8126-9583","authenticated-orcid":false,"given":"Andrew","family":"Flett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cebula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Ewings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John GF","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zina","family":"Eminton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Curzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2023.09.008_bib0001","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1161\/01.CIR.88.6.2953","article-title":"Sudden death prevention in patients with advanced ventricular dysfunction","volume":"88","author":"Stevenson","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.09.008_bib0002","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0735-1097(00)00728-2","article-title":"Circadian rhythm and sudden death in heart failure: results from Prospective Randomized Amlodipine Survival Trial","volume":"36","author":"Carson","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.09.008_bib0003","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/0002-9149(87)91183-0","article-title":"Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy","volume":"59","author":"Likoff","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2023.09.008_bib0004","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/0002-8703(92)90989-9","article-title":"Sudden death in idiopathic dilated cardiomyopathy","volume":"124","author":"Tamburro","year":"1992","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2023.09.008_bib0005","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.09.008_bib0006","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.09.008_bib0007","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/pace.12891","article-title":"Changes in implantation patterns and therapy rates of implantable cardioverter defibrillators over time in ischemic and dilated cardiomyopathy patients","volume":"39","author":"Vandenberk","year":"2016","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ahj.2023.09.008_bib0008","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.hrthm.2015.08.020","article-title":"Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: from the Israeli ICD Registry","volume":"12","author":"Sabbag","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2023.09.008_bib0009","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurheartj\/eht511","article-title":"Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark","volume":"35","author":"Kirkfeldt","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.09.008_bib0010","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa071098","article-title":"Prognostic importance of defibrillator shocks in patients with heart failure","volume":"359","author":"Poole","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.09.008_bib0011","first-page":"270","article-title":"A systematic review and meta-analysis of the association between implantable cardioverter-defibrillator shocks and long-term mortality","volume":"31","author":"Proietti","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ahj.2023.09.008_bib0012","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","article-title":"Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT)","volume":"105","author":"B\u00e4nsch","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.09.008_bib0013","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","article-title":"Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia\u2013AMIOVIRT","volume":"41","author":"Strickberger","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.09.008_bib0014","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.09.008_bib0015","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.09.008_bib0016","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1001\/jama.292.23.2874","article-title":"Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"292","author":"Desai","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2023.09.008_bib0017","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.jacc.2004.08.054","article-title":"Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials","volume":"44","author":"Nanthakumar","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.09.008_bib0018","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/europace\/euq329","article-title":"Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis","volume":"12","author":"Theuns","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2023.09.008_bib0019","first-page":"k4080","volume":"362","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2023.09.008_bib0020","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.09.008_bib0021","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2023.09.008_bib0022","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.09.008_bib0023","first-page":"e1","article-title":"[2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]","volume":"24","year":"2023","journal-title":"G Ital Cardiol (Rome)"},{"key":"10.1016\/j.ahj.2023.09.008_bib0024","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of Heart Failure: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.09.008_bib0025","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1542-474X.2012.00531.x","article-title":"Multicenter automatic defibrillator implantation trial: reduce inappropriate therapy (MADIT-RIT): background, rationale, and clinical protocol","volume":"17","author":"Schuger","year":"2012","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.ahj.2023.09.008_bib0026","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10741-018-9671-6","article-title":"Prophylactic use of the implantable cardioverter-defibrillator and its effect on the long-term survival, cardiovascular and sudden cardiac death in nonischemic cardiomyopathy patients-a systematic review and meta-analysis","volume":"23","author":"Siddiqui","year":"2018","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.ahj.2023.09.008_bib0027","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/joa3.12017","article-title":"Implantable cardioverter defibrillator in nonischemic cardiomyopathy: a systematic review and meta-analysis","volume":"34","author":"Khan","year":"2018","journal-title":"J Arrhythm"},{"key":"10.1016\/j.ahj.2023.09.008_bib0028","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00392-017-1079-0","article-title":"Implantable cardioverter\/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials","volume":"106","author":"Wolff","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ahj.2023.09.008_bib0029","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/jce.13204","article-title":"Implantable cardioverter defibrillators for primary prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"28","author":"Stavrakis","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ahj.2023.09.008_bib0030","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/jce.13192","article-title":"Mortality effect of ICD in primary prevention of nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"28","author":"Luni","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ahj.2023.09.008_bib0031","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016352","article-title":"Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trials","volume":"7","author":"Barakat","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.ahj.2023.09.008_bib0032","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jacep.2017.02.006","article-title":"Efficacy of implantable cardioverter-defibrillator therapy in patients with nonischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials","volume":"3","author":"Anantha Narayanan","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.ahj.2023.09.008_bib0033","doi-asserted-by":"crossref","first-page":"e12253","DOI":"10.1111\/1755-5922.12253","article-title":"Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis","volume":"35","author":"Akel","year":"2017","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.ahj.2023.09.008_bib0034","article-title":"Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy","volume":"12","author":"El Moheb","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ahj.2023.09.008_bib0035","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/europace\/eux089","article-title":"Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey","volume":"19","author":"Haugaa","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2023.09.008_bib0036","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2023.09.008_bib0037","doi-asserted-by":"crossref","first-page":"e12420","DOI":"10.1111\/anec.12420","article-title":"Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): study protocol for a randomized controlled trial","volume":"22","author":"Selvanayagam","year":"2017","journal-title":"Ann Noninvas Electrocardiol"},{"key":"10.1016\/j.ahj.2023.09.008_bib0038","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2004.01.029","article-title":"Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars","volume":"43","author":"Soejima","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.09.008_bib0039","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/CIRCIMAGING.113.001144","article-title":"Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis","volume":"7","author":"Kuruvilla","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.ahj.2023.09.008_bib0040","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.crad.2015.05.007","article-title":"Prognostic value of late gadolinium enhancement in dilated cardiomyopathy patients: a meta-analysis","volume":"70","author":"Duan","year":"2015","journal-title":"Clin Radiol"},{"key":"10.1016\/j.ahj.2023.09.008_bib0041","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","article-title":"Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Di Marco","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ahj.2023.09.008_bib0042","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jcmg.2016.01.033","article-title":"Myocardial fibrosis assessment by LGE is a powerful predictor of ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction: A meta-analysis","volume":"9","author":"Disertori","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ahj.2023.09.008_bib0043","doi-asserted-by":"crossref","first-page":"13775","DOI":"10.1038\/s41598-023-41087-4","article-title":"Impact of late gadolinium-enhanced cardiac MRI on arrhythmic and mortality outcomes in nonischemic dilated cardiomyopathy: updated systematic review and meta-analysis","volume":"13","author":"Theerasuwipakorn","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.ahj.2023.09.008_bib0044","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jacc.2010.06.062","article-title":"Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death","volume":"57","author":"Iles","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.09.008_bib0045","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/eurheartj\/ehy437","article-title":"Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar","volume":"40","author":"Gutman","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.09.008_bib0046","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ahj.2019.10.020","article-title":"Myocardial fibrosis and the effect of primary prophylactic defibrillator implantation in patients with non-ischemic systolic heart failure\u2014DANISH-MRI","volume":"221","author":"Elming","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2023.09.008_bib0047","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10840-019-00662-4","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"59","author":"Stiles","year":"2020","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.ahj.2023.09.008_bib0048","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s13063-019-3578-y","article-title":"Progression criteria in trials with an internal pilot: an audit of publicly funded randomised controlled trials","volume":"20","author":"Herbert","year":"2019","journal-title":"Trials"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323002818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323002818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:11:21Z","timestamp":1757571081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870323002818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":48,"alternative-id":["S0002870323002818"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2023.09.008","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and study protocol for the BRITISH randomized trial (Using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy and severe systolic heart failure)","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2023.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}